Ablynx’ vobarilizumab fails in lupus trial

27th March 2018 Uncategorised 0

Ablynx’ vobarilizumab has failed to hit targets in a mid-stage trial assessing its safety and effectiveness as a treatment for systemic lupus erythematosus (SLE).

More: Ablynx’ vobarilizumab fails in lupus trial
Source: News